Impacts of Rivaroxaban on Functional Outcomes in Patients with Lower-extremity Peripheral Artery Disease Following Endovascular Revascularization: A Randomized Double-blinded Controlled Trial
{{output}}
Background: Rivaroxaban (RIVA) is a medication with anti-inflammatory and anticoagulant properties that may slow the progression of peripheral artery disease (PAD). This trial evaluated the effects of RIVA on functional outcomes ... ...
